• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does Mechanical Circulatory Support-Assisted Percutaneous Coronary Intervention Improve Left Ventricular Function?

作者信息

Fahed Akl C, Jaffer Farouc A

机构信息

Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Cardiovascular Disease Initiative, Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.

出版信息

J Soc Cardiovasc Angiogr Interv. 2022 Aug 13;1(5):100387. doi: 10.1016/j.jscai.2022.100387. eCollection 2022 Sep-Oct.

DOI:10.1016/j.jscai.2022.100387
PMID:39131479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11308746/
Abstract
摘要

相似文献

1
Does Mechanical Circulatory Support-Assisted Percutaneous Coronary Intervention Improve Left Ventricular Function?机械循环支持辅助经皮冠状动脉介入治疗能否改善左心室功能？
J Soc Cardiovasc Angiogr Interv. 2022 Aug 13;1(5):100387. doi: 10.1016/j.jscai.2022.100387. eCollection 2022 Sep-Oct.
2
Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.缺血性心肌病患者行高风险经皮冠状动脉介入治疗后左心室功能改善。
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):764-770. doi: 10.1002/ccd.28557. Epub 2019 Nov 6.
3
[Effects of percutaneous coronary intervention on cardiac function in ischemic cardiomyopathy patients with different left ventricular ejection fraction and SYNTAX score≤22].经皮冠状动脉介入治疗对不同左心室射血分数且SYNTAX评分≤22的缺血性心肌病患者心功能的影响
Zhonghua Yi Xue Za Zhi. 2020 Sep 22;100(35):2768-2773. doi: 10.3760/cma.j.cn112137-20200116-00106.
4
Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.经皮冠状动脉介入治疗联合 Impella 对广泛病变伴左心功能不良患者左心室功能恢复的影响。
Int J Cardiol. 2023 Sep 15;387:131098. doi: 10.1016/j.ijcard.2023.05.048. Epub 2023 Jun 7.
5
Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support.使用机械循环支持对血流动力学不稳定的室性心动过速进行导管消融。
Int J Cardiol. 2013 Oct 9;168(4):3859-65. doi: 10.1016/j.ijcard.2013.06.035. Epub 2013 Jul 15.
6
Effectiveness of a percutaneous left ventricular assist device in preventing acute hemodynamic decompensation during catheter ablation of ventricular tachycardia in advanced heart failure patients: A retrospective single-center analysis.经皮左心室辅助装置在预防晚期心力衰竭患者室性心动过速导管消融过程中急性血液动力学恶化的效果：一项回顾性单中心分析。
J Cardiovasc Electrophysiol. 2019 Dec;30(12):2864-2868. doi: 10.1111/jce.14199. Epub 2019 Oct 2.
7
Left brachial artery: one more way to percutaneous insertion of IMPELLA 2.5L circulatory support for high-risk percutaneous coronary intervention - a case report.左肱动脉：经皮插入IMPELLA 2.5L循环支持装置用于高危经皮冠状动脉介入治疗的另一种途径——病例报告
Eur Heart J Case Rep. 2020 Oct 21;4(6):1-5. doi: 10.1093/ehjcr/ytaa281. eCollection 2020 Dec.
8
Coronary artery bypass grafting under sole Impella 5.0 support for patients with severely depressed left ventricular function.仅在Impella 5.0支持下对左心室功能严重受损患者进行冠状动脉旁路移植术。
J Artif Organs. 2022 Jun;25(2):158-162. doi: 10.1007/s10047-021-01285-1. Epub 2021 Jun 24.
9
Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.围生期心肌病并发心原性休克：早期左心室减压和溴隐亭治疗的重要性。
Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(2):173-182. doi: 10.1177/2048872618777876. Epub 2018 May 24.
10
Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.选择性Impella辅助高危经皮冠状动脉介入治疗的可行性和长期安全性：一项双中心试点研究。
J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):1004-10. doi: 10.2459/JCM.0b013e3282f9abe7.

本文引用的文献

1
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.
2
Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.新发心力衰竭患者的冠状动脉疾病检测的变异性。
J Am Coll Cardiol. 2022 Mar 8;79(9):849-860. doi: 10.1016/j.jacc.2021.11.061.
3
The Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease (OPTIMUM) Registry: Rationale and Design.经皮血运重建术治疗多支血管病变或左主干冠状动脉疾病（OPTIMUM）手术禁忌患者的结局：原理与设计。
Cardiovasc Revasc Med. 2022 Aug;41:83-91. doi: 10.1016/j.carrev.2022.01.008. Epub 2022 Jan 31.
4
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021年美国心脏病学会/美国心脏协会/心血管造影和介入学会冠状动脉血运重建指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 Jan 18;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038. Epub 2021 Dec 9.
5
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial.稳定性缺血性心脏病患者有心力衰竭或左心室功能障碍病史时的初始侵入性与保守性管理：来自 ISCHEMIA 试验的见解。
Circulation. 2020 Nov 3;142(18):1725-1735. doi: 10.1161/CIRCULATIONAHA.120.050304. Epub 2020 Aug 29.
6
Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry.依帕伐保护下经皮冠状动脉介入治疗中复杂高危和适应证患者的血运重建程度的长期结果：来自罗马-维罗纳注册研究的报告。
J Interv Cardiol. 2019 Apr 9;2019:5243913. doi: 10.1155/2019/5243913. eCollection 2019.
7
Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.缺血性心肌病患者行高风险经皮冠状动脉介入治疗后左心室功能改善。
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):764-770. doi: 10.1002/ccd.28557. Epub 2019 Nov 6.
8
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy.心肌活力与缺血性心肌病的长期预后
N Engl J Med. 2019 Aug 22;381(8):739-748. doi: 10.1056/NEJMoa1807365.
9
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.新型经皮冠状动脉血运重建术治疗初发三血管病变患者的临床结局：SYNTAX II 研究 1 年结果。
Eur Heart J. 2017 Nov 7;38(42):3124-3134. doi: 10.1093/eurheartj/ehx512.
10
Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的无保护左主干或多支冠状动脉疾病患者的手术禁忌和死亡率
Circulation. 2014 Dec 23;130(25):2295-301. doi: 10.1161/CIRCULATIONAHA.114.011541. Epub 2014 Nov 12.